Azerbaijan women behind global average for thalassemia screening and genetic counseling: Report

5.2% of the global population carry hemoglobin abnormalities, resulting in 300,000 to 400,000 children born with severe hemoglobinopathies annually. Thalassemia, a hereditary hemoglobinopathy, occurs in 4.4 out of every 10,000 live births and is prevalent in Mediterranean coastal areas, Africa, the Middle East, Southeast Asia, and southern China.

Consumption of antibiotics in the community back to pre-pandemic levels in the European Union and European Economic Area

This year’s European Antibiotic Awareness Day (EAAD) focuses on the targets outlined in the 2023 Council Recommendation to step up efforts in the European Union (EU) against antimicrobial resistance in a One Health approach. Those recommendations formulate the 2023 goal to reduce total antibiotic consumption (community and hospital sectors combined) by 20%, using consumption data from 2019 as a baseline.

COVID-19: Vaccination and infection found to trigger differential immune responses

It was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scientists from the University Medical Center Göttingen (UMG), in collaboration with the University of Münster, has now investigated this question in the CoV-ADAPT study (“Humoral and cellular immune responses of the adaptive immune system after vaccination or natural COVID infection”).

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

Multiple myeloma is still an incurable hematological malignancy. One of the reasons is that myeloma cells can be heterogenous and acquire resistance after anti-myeloma treatment. Immunotherapy is an attractive strategy to target myeloma cells with drug resistance. A next-generation modality that can safely and effectively strengthen immunotherapeutic effects while overcoming the characteristics of myeloma cells is needed in order to break through these obstacles.